CDNA Caredx Earnings and EPS analysis

Relative Growth: Rel. Growth: 90

Relative Strength: Rel. Strength: 99

Relative Valuation: Rel. Valuation: 60

Relative Profitability: Rel. Profitability: 97

EPS in 2026 (TTM): $2.15

Last Report Period Date: Jun 30, 2026

Currently, CDNA's 12-month EPS stands at $2.15, according to the most recent financial reports. During 2025, CDNA reported a per-share earnings of -$0.4, which shows a decline compared to the EPS of $1 recorded in 2024. CDNA recorded an EPS of $2.15 for the quarterly period ending on Jun 30, 2026.

CDNA earnings history

Historical annual and quarterly earnings per share (EPS) data for Caredx

EPS (TTM)

$2.15

EPS Growth YoY (Quarterly)

1,443.8%

EPS (Quarterly)

$2.15

EPS Growth (Quarterly)

4,200%

In 2025, Caredx's earnings per share was -$0.4, a decline of 140% from $1 in 2024. Over the quarter ending Jun 30, 2026, the earnings per share came in at $2.15, reflecting a 1,443.8% increase compared to the same quarter a year earlier. As of June 2026, the TTM EPS is $2.15. During 2024, the annual earnings per share was $1, representing an increase of 128.2% compared to 2023.

CDNA EPS vs price chart

CDNA EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

1,443.8%

EPS growth YoY

-140%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Caredx has recorded a growth in earnings per share of 1,443.8% in the past 12 months (YoY, quarterly).

CDNA Earnings Waterfall

Breakdown of revenue, profit and net income for Caredx

CDNA Earnings vs Peers

What are the earnings of CDNA compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
CDNA Caredx Inc	24.35	-140%	N/A	N/A
AGIO Agios Pharmaceuticals Inc	N/A	-160%	N/A	N/A
ARDX Ardelyx Inc	N/A	-52.9%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.